BrightSpring Health Services, Inc. provided earnings guidance for the full year of 2024. For the year, the company expects net revenue to be between $9,350 million to $9,500 million, or 5.9% to 7.6% growth over 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.25 USD | -1.75% | -0.62% | -.--% |
May. 22 | BrightSpring Health Services Completes Three Acquisitions | MT |
May. 20 | BrightSpring Health Services Says Onco360 Selected as Pharmacy Partner for Ojemda | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.93B | |
-4.11% | 2.98B | |
+23.65% | 1.86B | |
-11.21% | 461M | |
-47.58% | 298M | |
-19.40% | 174M | |
-16.45% | 131M | |
+1.92% | 67.77M |
- Stock Market
- Equities
- BTSG Stock
- News BrightSpring Health Services, Inc.
- BrightSpring Health Services, Inc. Provides Earnings Guidance for the Full Year of 2024